HRMY vs. ILMN: Which Stock Should Value Investors Buy Now?

Core Insights - Harmony Biosciences Holdings, Inc. (HRMY) is currently viewed as a more attractive investment compared to Illumina (ILMN) for those seeking undervalued stocks [1][3][7] Valuation Metrics - HRMY has a forward P/E ratio of 11.28, significantly lower than ILMN's forward P/E of 23.26, indicating HRMY may be undervalued [5] - The PEG ratio for HRMY is 0.48, while ILMN's PEG ratio stands at 1.93, suggesting HRMY has better earnings growth potential relative to its price [5] - HRMY's P/B ratio is 2.76 compared to ILMN's P/B of 6.59, further supporting the notion that HRMY is undervalued [6] Earnings Outlook - HRMY is experiencing an improving earnings outlook, which enhances its attractiveness in the Zacks Rank model [7]